Abstract
Correction: Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter clinical study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have